DE60034117D1 - Verfahren zur herstelllung von gonadotropin-zusammensetzungen - Google Patents

Verfahren zur herstelllung von gonadotropin-zusammensetzungen

Info

Publication number
DE60034117D1
DE60034117D1 DE60034117T DE60034117T DE60034117D1 DE 60034117 D1 DE60034117 D1 DE 60034117D1 DE 60034117 T DE60034117 T DE 60034117T DE 60034117 T DE60034117 T DE 60034117T DE 60034117 D1 DE60034117 D1 DE 60034117D1
Authority
DE
Germany
Prior art keywords
gonadotropins
menotropins
follitropin
fsh
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60034117T
Other languages
English (en)
Other versions
DE60034117T2 (de
Inventor
Band Claudio Fernand Wolfenson
Liliana Ester Balanian
Jose Felipe Groisman
Erundina Marta Fasanella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Instituto Massone SA
Original Assignee
Instituto Massone SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto Massone SA filed Critical Instituto Massone SA
Application granted granted Critical
Publication of DE60034117D1 publication Critical patent/DE60034117D1/de
Publication of DE60034117T2 publication Critical patent/DE60034117T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60034117T 1999-04-16 2000-04-14 Verfahren zur herstelllung von gonadotropin-zusammensetzungen Expired - Lifetime DE60034117T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12954099P 1999-04-16 1999-04-16
US129540P 1999-04-16
PCT/EP2000/003357 WO2000063248A2 (en) 1999-04-16 2000-04-14 Highly purified gonadotropin compositions and process for preparing them

Publications (2)

Publication Number Publication Date
DE60034117D1 true DE60034117D1 (de) 2007-05-10
DE60034117T2 DE60034117T2 (de) 2007-12-13

Family

ID=22440494

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60034117T Expired - Lifetime DE60034117T2 (de) 1999-04-16 2000-04-14 Verfahren zur herstelllung von gonadotropin-zusammensetzungen

Country Status (13)

Country Link
EP (1) EP1169349B1 (de)
JP (1) JP4574865B2 (de)
AT (1) ATE358139T1 (de)
AU (1) AU779005B2 (de)
BR (1) BRPI0010677B8 (de)
CA (1) CA2370225C (de)
CY (1) CY1107666T1 (de)
DE (1) DE60034117T2 (de)
DK (1) DK1169349T3 (de)
ES (1) ES2284494T3 (de)
MX (1) MXPA01010522A (de)
PT (1) PT1169349E (de)
WO (1) WO2000063248A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4763616B2 (ja) 2003-12-22 2011-08-31 アレス トレーディング ソシエテ アノニム Fshを精製するための方法
MX2007005327A (es) * 2004-11-09 2007-08-02 Ares Trading Sa Metodo para purificacion de la hormona foliculo estimulante (hfe).
UA87709C2 (ru) * 2004-11-09 2009-08-10 Эйрэс Трейдинг С.А. Способ очищения фолликулостимулирующего гормона
SG155183A1 (en) 2005-08-26 2009-09-30 Ares Trading Sa Process for the preparation of glycosylated interferon beta
AU2006323925B2 (en) 2005-12-09 2012-08-02 Ares Trading S.A. Method for purifying FSH or a FSH mutant
UA103598C2 (uk) 2007-06-28 2013-11-11 Биодженерикс Аг Клон клітин, що продукують fsh
WO2009098318A1 (en) 2008-02-08 2009-08-13 Biogenerix Ag Liquid formulation of fsh
CN101269215B (zh) * 2008-05-15 2011-03-23 上海天伟生物制药有限公司 一种糖蛋白激素组合物
AU2010234028B2 (en) * 2009-04-01 2013-11-14 Theramex HQ UK Limited Method for purifying recombinant FSH
EP2325194A1 (de) 2009-11-24 2011-05-25 Glycotope GmbH Verfahren zur Reinigung von Glykoproteinen
CN103159846B (zh) * 2013-04-09 2015-04-22 邹平县滨渤生物科技有限公司 Hmg粗品的制备方法
JP6647220B2 (ja) * 2014-05-23 2020-02-14 インスティトゥート・マッソーネ・エセ・ア Hmg−up(超高純度グレードのヒト閉経期ゴナドトロピン)を得るための方法及び夾雑物を含まない組成物
PL3261661T3 (pl) 2015-02-26 2024-03-25 Ferring B.V. Menotropina do leczenia niepłodności
CN108070640B (zh) * 2018-01-12 2021-09-21 浙江省农业科学院 一种与卵泡刺激素剂量呈线性相关的基因的筛选方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1065127A (en) * 1963-03-11 1967-04-12 Serono Ist Farm Pituitary gonadotropic hormone preparation and method for its production
IT1287138B1 (it) * 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh

Also Published As

Publication number Publication date
CA2370225A1 (en) 2000-10-26
MXPA01010522A (es) 2003-08-19
BR0010677B1 (pt) 2013-04-30
CA2370225C (en) 2010-06-29
WO2000063248A2 (en) 2000-10-26
ES2284494T3 (es) 2007-11-16
BR0010677A (pt) 2002-02-05
DE60034117T2 (de) 2007-12-13
AU4549100A (en) 2000-11-02
JP4574865B2 (ja) 2010-11-04
PT1169349E (pt) 2007-06-18
CY1107666T1 (el) 2013-04-18
EP1169349A2 (de) 2002-01-09
BRPI0010677B8 (pt) 2021-05-25
ATE358139T1 (de) 2007-04-15
WO2000063248A3 (en) 2001-02-01
JP2002542260A (ja) 2002-12-10
DK1169349T3 (da) 2007-07-30
AU779005B2 (en) 2004-12-23
EP1169349B1 (de) 2007-03-28

Similar Documents

Publication Publication Date Title
CY1107666T1 (el) Διαδικασια για την παρασκευη συνθεσεων γοναδοτροπινης
Al-Obeidi et al. Potent and prolonged-acting cyclic lactam analogs of. alpha.-melanotropin: design based on molecular dynamics
Low et al. Chemical characterization of thymosin beta 4.
Rattenholl et al. Pro-sequence assisted folding and disulfide bond formation of human nerve growth factor
Violette et al. Large-scale discovery of conopeptides and conoproteins in the injectable venom of a fish-hunting cone snail using a combined proteomic and transcriptomic approach
ATE551423T1 (de) Sequenzen von hepatitis c virus-genotypen sowie ihre verwendungen als therapeutika und diagnostika
DK1179067T3 (da) Neurobeskyttende egenskaber hos GDF-15, et medlem af TGF-beta-superfamilien
NZ503489A (en) Natural humanized antibody, method of production and pharmaceutical composition
DE59712555D1 (de) Exendin-analoga, verfahren zu deren herstellung und diese enthaltende arzneimittel
EP2289550A3 (de) Neutralisierende Antikörper mit ultrahoher Affinität
BR0008688A (pt) Antagonistas de il-18 recombinantes utilizáveis no tratamento de distúrbios mediados por il-18
Butler et al. Chemical studies on the cyanogen bromide peptides of rat skin collagen. Amino acid sequence of α1-CB4
Roggero et al. A simple and rapid procedure for the purification of synthetic polypeptides by a combination of affinity chromatography and methionine chemistry
Dadlez et al. A third native one-disulphide intermediate in the folding of bovine pancreatic trypsin inhibitor
EP1258494A1 (de) Multiprotein-Komplexe von Eukaryonten
JPS61109798A (ja) ペプチドの製造及び精製方法
ATE83242T1 (de) Cysteinreiche, gamma-glutaminsaeure und betaalanin-einheitenaufweisende peptide, verfahren zu deren herstellung und ihre verwendung.
DE60310958T2 (de) Synthese und charakterisierung neuer systeme zum hinführen und zur vektorisierung von molekülen von therapeutischem interesse zu targetzellen
ATE472337T1 (de) Pharmazeutische zusammensetzung aus f(ab) 2- fragmenten von antikörpern und verfahren zu ihrer herstellung
Spetzler et al. A novel strategy for the synthesis of the cysteine‐rich protective antigen of the malaria merozoite surface protein (MSP‐1) Knowledge‐based strategy for disulfide formation
MY120085A (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines.
EP0700928A1 (de) Nukleinsäuren-bindende Oligomere für Therapie und Diagnostik
Büllesbach et al. Relaxin structure. Quasi allosteric effect of the NH2-terminal A-chain helix.
WO2004005882A3 (en) Multi-parameter high throughput screening assays (mphts)
EP0364942B1 (de) Neue Isohirudine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition